newsfilter
← Latest News
GlobeNewswire·

NexImmune Announces Poster Presentation at the 2023 FOCIS Annual Meeting

AIM nanoparticle approach can identify select EBV-specific T cell defects in patients with multiple sclerosis and may enable killing of EBV+ cells believed to be a contributing factor in this disease Data suggests a